Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01070056 · ClinicalTrials.gov registry record · Phase 3

Practice-based Trial of Blood Pressure Control in African Americans

A Phase 3 study, sponsored by NYU Langone Health.

Completed
Registry status
Phase 3
Development phase
194
Enrollment target

NCT01070056: Completed Phase 3 study, sponsored by NYU Langone Health.

NCT01070056 is a Phase 3 study that has completed, run by NYU Langone Health. The registered enrollment target is 194 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01070056, a Phase 3 study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
Phase 3
Development phase
194 participants
Enrollment target

Study Summary

Poorly controlled hypertension (HTN) remains one of the most significant public health problems in the United States, in terms of morbidity, mortality, and economic burden. Despite compelling evidence supporting the beneficial effects of therapeutic lifestyle changes (TLC) on blood pressure (BP) reduction, their effectiveness remains untested in primary care practices, especially among minority patients who share a greater burden of HTN-related outcomes including chronic kidney disease, stroke and heart failure. This randomized controlled trial offers a unique opportunity to address this gap in the literature. Among 200 hypertensive African-Americans who receive care in community- based primary care practices, we will test the effectiveness of a culturally-tailored comprehensive therapeutic lifestyle intervention, delivered through group-based counseling and motivational interviewing (MINT-TLC) vs. Usual Care (UC). MINT-TLC is designed to help patients make appropriate TLC and develop skills to maintain these changes long-term. Patients in the MINT-TLC group will attend weekly group classes focused on TLC for 12 weeks (intensive phase); followed by individual motivational interviewing (MINT) sessions for 3 months (maintenance phase). Trained research personnel will deliver MINT-TLC with appropriate treatment fidelity procedures. Patients in the UC condition will receive a single individual counseling session on TLC and print versions of the intervention materials. The primary outcome is within-patient change in both systolic and diastolic blood pressure from baseline to 6 months. Secondary outcomes are levels of targeted therapeutic lifestyle behaviors; and proportion of patients with adequate blood pressure control at 6 months

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Therapeutic Lifestyle Changes (MINT-TLC)

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2010-02
Est. Completion 2012-07
Phase Phase 3
NYU Langone Health

1,164 total trials

What the finished NCT01070056 record still lists

NCT01070056 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT01070056 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01070056 about?

NCT01070056 is a clinical study titled "Practice-based Trial of Blood Pressure Control in African Americans". Poorly controlled hypertension (HTN) remains one of the most significant public health problems in the United States, in terms of morbidity, mortality, and economic burden. Despite compelling evidence supporting the beneficial effects of therapeutic lifestyle changes (TLC) on blood pressure (BP) red...

What is the current status of trial NCT01070056?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 194 participants. The study started on 2010-02. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01070056?

The interventions under investigation include: Usual Care (BEHAVIORAL), Therapeutic Lifestyle Changes (MINT-TLC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01070056?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01070056's enrollment target sits among peer trials

194 1395th of 2000 higher than 604 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03593759 · 194 participants · Phase 3

    Cardiac Sarcoidosis Randomized Trial

  • NCT05053152 · 194 participants · Phase 2

    Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

  • NCT05156112 · 194 participants · NA

    OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit

  • NCT05351424 · 194 participants · NA

    AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01070056, the US trial registry maintained by the National Library of Medicine. NCT01070056 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.